AP-HP, Biochimie Métabolique et Cellulaire, Hôpital Bichat-Claude Bernard, Paris, France.
INSERM UMR1193, Université Paris-Saclay, 92290 Châtenay-Malabry, France.
Clin Chim Acta. 2021 Oct;521:104-106. doi: 10.1016/j.cca.2021.07.005. Epub 2021 Jul 8.
SLC37A4-CDG is an emerging congenital disorder of glycosylation which is characterized by a dominant inheritance and a major coagulopathy originating from the liver. Recent studies took interest in the biochemical alterations found in this CDG and showed that they consisted of multiple glycosylation abnormalities, which result from mislocalization of the endoplasmic reticulum glucose-6-phosphate transporter and associated Golgi homeostasis defects. In this work, we highlight in six affected individuals abnormal patterns for various serum N-glycoproteins and bikunin proteoglycan isoforms, together with specific alterations of the mass spectra of endoglycosidase H-released serum N-glycans. Collectively, these data complement previous findings, help to better delineate SLC37A4-CDG and could present interest in diagnosing this disease.
SLC37A4-CDG 是一种新兴的伴显性遗传的先天性糖基化缺陷疾病,其特征为以肝脏来源的严重凝血功能障碍。最近的研究对该疾病的生化改变产生了兴趣,发现其包含多种糖基化异常,这是由于内质网葡萄糖-6-磷酸转运蛋白的定位错误和相关高尔基体稳态缺陷所致。在这项工作中,我们在 6 名受影响个体中强调了各种血清 N-糖蛋白和 bikunin 蛋白聚糖同工型的异常模式,以及内切糖苷酶 H 释放的血清 N-糖链的质谱的特定改变。总的来说,这些数据补充了之前的发现,有助于更好地区分 SLC37A4-CDG,并可能有助于该疾病的诊断。